Although recent studies have shown a CADM1 loss at the protein and messenger RNA levels in high-grade (World Health Organization III/IV) glioma compared with low-grade glioma [58], the fact that we found this interaction mainly in patients with GBM in association with infiltrating CD8+ T cells further supports the tumor suppressor role of this gene. This evidence concerns the gene CADM1 and central nervous system cancer.